549 related articles for article (PubMed ID: 23340503)
1. Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder.
Frye RE; Melnyk S; Macfabe DF
Transl Psychiatry; 2013 Jan; 3(1):e220. PubMed ID: 23340503
[TBL] [Abstract][Full Text] [Related]
2. Redox metabolism abnormalities in autistic children associated with mitochondrial disease.
Frye RE; Delatorre R; Taylor H; Slattery J; Melnyk S; Chowdhury N; James SJ
Transl Psychiatry; 2013 Jun; 3(6):e273. PubMed ID: 23778583
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of mitochondrial dysfunction in autism spectrum disorder: A systematic review and meta-analysis.
Frye RE; Rincon N; McCarty PJ; Brister D; Scheck AC; Rossignol DA
Neurobiol Dis; 2024 Jul; 197():106520. PubMed ID: 38703861
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis.
Rossignol DA; Frye RE
Mol Psychiatry; 2012 Mar; 17(3):290-314. PubMed ID: 21263444
[TBL] [Abstract][Full Text] [Related]
5. Acyl-carnitine, C5DC, and C26 as potential biomarkers for diagnosis of autism spectrum disorder in children.
Lv QQ; You C; Zou XB; Deng HZ
Psychiatry Res; 2018 Sep; 267():277-280. PubMed ID: 29945069
[TBL] [Abstract][Full Text] [Related]
6. Altered brain phospholipid and acylcarnitine profiles in propionic acid infused rodents: further development of a potential model of autism spectrum disorders.
Thomas RH; Foley KA; Mepham JR; Tichenoff LJ; Possmayer F; MacFabe DF
J Neurochem; 2010 Apr; 113(2):515-29. PubMed ID: 20405543
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome.
Frye RE; Rose S; Slattery J; MacFabe DF
Microb Ecol Health Dis; 2015; 26():27458. PubMed ID: 25956238
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial dysfunction in autism.
Legido A; Jethva R; Goldenthal MJ
Semin Pediatr Neurol; 2013 Sep; 20(3):163-75. PubMed ID: 24331358
[TBL] [Abstract][Full Text] [Related]
9. Modulation of mitochondrial function by the microbiome metabolite propionic acid in autism and control cell lines.
Frye RE; Rose S; Chacko J; Wynne R; Bennuri SC; Slattery JC; Tippett M; Delhey L; Melnyk S; Kahler SG; MacFabe DF
Transl Psychiatry; 2016 Oct; 6(10):e927. PubMed ID: 27779624
[TBL] [Abstract][Full Text] [Related]
10. Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders.
Macfabe DF
Microb Ecol Health Dis; 2012; 23():. PubMed ID: 23990817
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Dysfunction in Autism Spectrum Disorder: Unique Abnormalities and Targeted Treatments.
Frye RE
Semin Pediatr Neurol; 2020 Oct; 35():100829. PubMed ID: 32892956
[TBL] [Abstract][Full Text] [Related]
12. Potential Role of L-Carnitine in Autism Spectrum Disorder.
Kępka A; Ochocińska A; Chojnowska S; Borzym-Kluczyk M; Skorupa E; Knaś M; Waszkiewicz N
J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33805796
[TBL] [Abstract][Full Text] [Related]
13. Clinical and Molecular Characteristics of Mitochondrial Dysfunction in Autism Spectrum Disorder.
Rose S; Niyazov DM; Rossignol DA; Goldenthal M; Kahler SG; Frye RE
Mol Diagn Ther; 2018 Oct; 22(5):571-593. PubMed ID: 30039193
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging.
Goh S; Dong Z; Zhang Y; DiMauro S; Peterson BS
JAMA Psychiatry; 2014 Jun; 71(6):665-71. PubMed ID: 24718932
[TBL] [Abstract][Full Text] [Related]
15. Carnitine deficiency disorders in children.
Stanley CA
Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
[TBL] [Abstract][Full Text] [Related]
16. Enteric bacterial metabolites propionic and butyric acid modulate gene expression, including CREB-dependent catecholaminergic neurotransmission, in PC12 cells--possible relevance to autism spectrum disorders.
Nankova BB; Agarwal R; MacFabe DF; La Gamma EF
PLoS One; 2014; 9(8):e103740. PubMed ID: 25170769
[TBL] [Abstract][Full Text] [Related]
17. Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial beta-oxidation by long chain acyl-CoA dehydrogenase.
Clark-Taylor T; Clark-Taylor BE
Med Hypotheses; 2004; 62(6):970-5. PubMed ID: 15142659
[TBL] [Abstract][Full Text] [Related]
18. Altered markers of mitochondrial function in adults with autism spectrum disorder.
Nickel K; Menke M; Endres D; Runge K; Tucci S; Schumann A; Domschke K; Tebartz van Elst L; Maier S
Autism Res; 2023 Nov; 16(11):2125-2138. PubMed ID: 37715660
[TBL] [Abstract][Full Text] [Related]
19. Autism spectrum disorders associated to a deficiency of the enzymes of the mitochondrial respiratory chain.
Guevara-Campos J; González-Guevara L; Puig-Alcaraz C; Cauli O
Metab Brain Dis; 2013 Dec; 28(4):605-12. PubMed ID: 23839164
[TBL] [Abstract][Full Text] [Related]
20. Medium-chain fatty acid oxidation is independent of l-carnitine in liver and kidney but not in heart and skeletal muscle.
Pereyra AS; McLaughlin KL; Buddo KA; Ellis JM
Am J Physiol Gastrointest Liver Physiol; 2023 Oct; 325(4):G287-G294. PubMed ID: 37461880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
